Concerns regarding “ GLP ‐ 1RA and the risk of non‐arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes”

Documenti analoghi

• GLP ‐ 1RA and the risk of non‐arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes: A population‐based study
  di: Helen Tesfaye, et al.
  Pubblicazione: (2025)
• Glucagon‐like peptide‐1 receptor agonists and the risk of nonarteritic anterior ischaemic optic neuropathy: A systematic review and meta‐analysis of observational studies
  di: Ronald M. Goldenberg, et al.
  Pubblicazione: (2025)
• Mortality risk following ischaemic and non‐ischaemic heart failure in people with type 2 diabetes: Observational study in England, 2000–2021
  di: Kajal Panchal, et al.
  Pubblicazione: (2025)
• Targeting the cholinergic anti‐inflammatory pathway for type 2 diabetes prevention: A retrospective cohort study
  di: Joseph Magagnoli, et al.
  Pubblicazione: (2024)
• The glucagon like peptide‐1 linked to nonarteritic anterior ischemic optic neuropathy
  di: Iskandar Idris
  Pubblicazione: (2024)